Jason R Gee

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. doi request reprint Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin
    Jason R Gee
    Department of Urology, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53792, USA
    BJU Int 103:736-9. 2009
  2. pmc Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer
    Jason R Gee
    Department of Urology, William S Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Anticancer Res 29:3769-75. 2009
  3. pmc Flexible and rigid cystoscopy in women
    Jason R Gee
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    JSLS 13:135-8. 2009
  4. doi request reprint Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
    Jason R Gee
    aUniversity of Wisconsin Carbone Cancer Center, Madison, Wisconsin bUrology San Antonio Research, San Antonio, Texas cUniversity of Rochester Medical Center, Rochester, New York dDivision of Cancer Prevention, National Institutes of Health, National Cancer Institute, Bethesda, Maryland, USA
    Eur J Cancer Prev 25:312-20. 2016
  5. ncbi request reprint Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques
    Gyan Pareek
    Division of Urology, Department of Surgery, University of Wisconsin Medical School, Madison, Wisconsin, USA
    J Urol 175:1208-13. 2006
  6. pmc A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
    Edward Messing
    University of Rochester Medical Center, Rochester, New York, USA
    Cancer Prev Res (Phila) 5:621-30. 2012
  7. pmc A Bayesian adaptive design with biomarkers for targeted therapies
    Jens C Eickhoff
    Department of Biostatistics and Medical Informatics, University of Wisconsin Madison, Madison, WI, USA
    Clin Trials 7:546-56. 2010

Detail Information

Publications7

  1. doi request reprint Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin
    Jason R Gee
    Department of Urology, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53792, USA
    BJU Int 103:736-9. 2009
    ....
  2. pmc Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer
    Jason R Gee
    Department of Urology, William S Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Anticancer Res 29:3769-75. 2009
    ..Here we investigate molecular effects of celecoxib independent of cyclooxygenase (COX)-2 expression levels in urothelial carcinoma of the bladder...
  3. pmc Flexible and rigid cystoscopy in women
    Jason R Gee
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    JSLS 13:135-8. 2009
    ..Similar studies, however, have not been performed in women. We sought to determine whether office-based flexible cystoscopy was better tolerated than rigid cystoscopy in women...
  4. doi request reprint Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
    Jason R Gee
    aUniversity of Wisconsin Carbone Cancer Center, Madison, Wisconsin bUrology San Antonio Research, San Antonio, Texas cUniversity of Rochester Medical Center, Rochester, New York dDivision of Cancer Prevention, National Institutes of Health, National Cancer Institute, Bethesda, Maryland, USA
    Eur J Cancer Prev 25:312-20. 2016
    ..This study demonstrates the feasibility of biologic evaluation of relatively nontoxic preventive agents in the preprostatectomy setting with the potential for rapid accrual. ..
  5. ncbi request reprint Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques
    Gyan Pareek
    Division of Urology, Department of Surgery, University of Wisconsin Medical School, Madison, Wisconsin, USA
    J Urol 175:1208-13. 2006
    ..We performed a meta-analysis of the literature to define the current expectations of complications during laparoscopic renal surgery...
  6. pmc A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
    Edward Messing
    University of Rochester Medical Center, Rochester, New York, USA
    Cancer Prev Res (Phila) 5:621-30. 2012
    ..Genistein displayed a possible bimodal effect (more effective at the lower dose) on bladder cancer tissue EGFR phosphorylation that should be evaluated further, possibly in combination with other agents...
  7. pmc A Bayesian adaptive design with biomarkers for targeted therapies
    Jens C Eickhoff
    Department of Biostatistics and Medical Informatics, University of Wisconsin Madison, Madison, WI, USA
    Clin Trials 7:546-56. 2010
    ..In traditional clinical trials, treatment effects for various biomarkers are typically evaluated in an exploratory fashion and only limited information about the predictive values of biomarkers obtained...